265 related articles for article (PubMed ID: 14763126)
1. Multidrug resistance in cancer therapy: role of the microenvironment.
Galmarini CM; Galmarini FC
Curr Opin Investig Drugs; 2003 Dec; 4(12):1416-21. PubMed ID: 14763126
[TBL] [Abstract][Full Text] [Related]
2. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
Malam Y; Loizidou M; Seifalian AM
Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467
[TBL] [Abstract][Full Text] [Related]
3. Drug penetration in solid tumours.
Minchinton AI; Tannock IF
Nat Rev Cancer; 2006 Aug; 6(8):583-92. PubMed ID: 16862189
[TBL] [Abstract][Full Text] [Related]
4. Freezing-assisted intracellular drug delivery to multidrug resistant cancer cells.
Teo KY; Han B
J Biomech Eng; 2009 Jul; 131(7):074513. PubMed ID: 19640149
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticles for delivery of chemotherapeutic agents to tumors.
Vijayaraghavalu S; Raghavan D; Labhasetwar V
Curr Opin Investig Drugs; 2007 Jun; 8(6):477-84. PubMed ID: 17621878
[TBL] [Abstract][Full Text] [Related]
6. Drug resistance mechanisms in cancer cells: a proteomics perspective.
Verrills NM; Kavallaris M
Curr Opin Mol Ther; 2003 Jun; 5(3):258-65. PubMed ID: 12870435
[TBL] [Abstract][Full Text] [Related]
7. Teaching new dogs old tricks: membrane biophysical properties in drug delivery and resistance.
Milosavljevic N; Blanchard A; Wahl ML; Harguindey S; Poet M; Counillon L; Rauch C
Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):334-46. PubMed ID: 21756245
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer.
Coley HM
Cancer Treat Rev; 2008 Jun; 34(4):378-90. PubMed ID: 18367336
[TBL] [Abstract][Full Text] [Related]
9. Liposomal cancer therapy: exploiting tumor characteristics.
Kaasgaard T; Andresen TL
Expert Opin Drug Deliv; 2010 Feb; 7(2):225-43. PubMed ID: 20095944
[TBL] [Abstract][Full Text] [Related]
10. [Resistance to chemotherapeutic agents in the treatment of cancer. Emphasizing the multiresistant phenotype].
Holte H
Tidsskr Nor Laegeforen; 1991 Aug; 111(19):2423-7. PubMed ID: 1926080
[TBL] [Abstract][Full Text] [Related]
11. Drug resistance in chemotherapy for breast cancer.
Saeki T; Tsuruo T; Sato W; Nishikawsa K
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():84-9. PubMed ID: 16273361
[TBL] [Abstract][Full Text] [Related]
12. Why chemotherapy can fail?
Król M; Pawłowski KM; Majchrzak K; Szyszko K; Motyl T
Pol J Vet Sci; 2010; 13(2):399-406. PubMed ID: 20731201
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of drug resistance.
Longley DB; Johnston PG
J Pathol; 2005 Jan; 205(2):275-92. PubMed ID: 15641020
[TBL] [Abstract][Full Text] [Related]
14. [Research advance on role of tumor microenvironment in mediating acquired drug resistance].
Ma XL; Xing H; Ma D
Ai Zheng; 2007 Aug; 26(8):923-6. PubMed ID: 17697561
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology applied to overcome tumor drug resistance.
Gao Z; Zhang L; Sun Y
J Control Release; 2012 Aug; 162(1):45-55. PubMed ID: 22698943
[TBL] [Abstract][Full Text] [Related]
16. Current clinical and research approaches to optimizing regional chemotherapy: novel strategies generated through a better understanding of drug pharmacokinetics, drug resistance, and the development of clinically relevant animal models.
Beasley GM; Kahn L; Tyler DS
Surg Oncol Clin N Am; 2008 Oct; 17(4):731-58, vii-viii. PubMed ID: 18722915
[TBL] [Abstract][Full Text] [Related]
17. Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor.
Yin Q; Shen J; Zhang Z; Yu H; Li Y
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1699-715. PubMed ID: 23611952
[TBL] [Abstract][Full Text] [Related]
18. Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death.
Hazlehurst LA; Landowski TH; Dalton WS
Oncogene; 2003 Oct; 22(47):7396-402. PubMed ID: 14576847
[TBL] [Abstract][Full Text] [Related]
19. Drug resistance in cancer - searching for mechanisms, markers and therapeutic agents.
O'Connor R; Clynes M; Dowling P; O'Donovan N; O'Driscoll L
Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):805-17. PubMed ID: 18028026
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic failure of antineoplastic agents. Extracellular and cellular causes].
Hofsli E
Tidsskr Nor Laegeforen; 1991 Jan; 111(1):37-40. PubMed ID: 2000585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
